Immunocore Holdings plc IMCR

Latest FY: 2025 Healthcare Biotechnology
Market Price $33.60
Market Cap $1.71B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑29.0% YoY
$400.02M
3-Yr CAGR: 40.7%
Net Income ↑35.6% YoY
-$45.35M
Net Margin: -11.3%
Free Cash Flow ↓-172.1% YoY
-$15.05M
FCF Yield: -0.88%
EPS (Diluted) ↑30.4% YoY
$-0.71
Basic: $-0.71
Return on Equity Efficiency
-11.9%
ROA: -4.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IMCR)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2019: Revenue YoY (+8.5%) is identical to Gross Profit YoY (+8.5%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
  • FY 2020: Revenue YoY (+17.3%) is identical to Gross Profit YoY (+17.3%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
  • FY 2021: Revenue YoY (-11.9%) is identical to Gross Profit YoY (-11.9%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $23.7M $5.9M $-88.2M $-3.32 $-16.6M $-20.1M
FY 2019 $25.7M +8.5% $6.4M $-126.2M -43.1% $-4.66 -40.4% $-101.4M $-105.5M -424.3%
FY 2020 $30.1M +17.3% $7.5M $-87.4M +30.8% $-2.79 +40.1% $-60.6M $-63.6M +39.6%
FY 2021 $26.5M -11.9% $6.6M $-140.9M -61.3% $-3.10 -11.1% 0.00% $-96.1M $-97.1M -52.6%
FY 2022 $143.7M +442.0% $141.9M $-44.1M +68.7% $-0.90 +71.0% 0.00% $-25.9M $-27.7M +71.5%
FY 2023 $249.4M +73.5% $244.3M $-59.6M -35.1% $-1.13 -25.6% 0.00% $2.9M $-2.5M +91.0%
FY 2024 $310.2M +24.4% $291.4M $-70.5M -18.1% $-1.02 +9.7% 0.00% $26.1M $20.9M +940.6%
FY 2025 $400.0M +29.0% $387.9M $-45.4M +35.6% $-0.71 +30.4% 0.00% $-10.7M $-15.1M -172.1%
$

Valuation

Market Price $33.60
Market Cap $1.71B
Enterprise Value $1.68B
P/E Ratio N/A
P/B Ratio 4.49
FCF Yield -0.88%
Dividend Yield 0.00%
Shares Outstanding 50,865,574
%

Profitability & Margins

Gross Margin 96.96%
Operating Margin -11.34%
Net Margin -11.34%
Return on Equity (ROE) -11.90%
Return on Assets (ROA) -4.25%
Asset Turnover 0.37x
Revenue 3-Yr CAGR 40.66%
🛡️

Financial Health & Liquidity

Current Ratio 4.04
Cash Ratio 1.90
Debt / Equity 1.146
Debt / Assets 0.409
Cash & Equivalents $467.71M
Total Debt $436.69M
Book Value / Share $7.49
💧

Cash Flow Efficiency

Operating Cash Flow -$10.71M
Capital Expenditures (CapEx) $4.34M
Free Cash Flow -$15.05M
OCF / Revenue -2.68%
FCF / Revenue -3.76%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.71
EPS (Basic) $-0.71
Dividends / Share N/A
Book Value / Share $7.49
EPS YoY Growth 30.39%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.07B
Total Liabilities $686.24M
Stockholders' Equity $381.03M
Current Assets $996.74M
Current Liabilities $246.70M